尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Loranger Steven R, 董事. Insider active across 2 companies, notably Edwards Lifesciences Corp. In total, 9 disclosures have been published. History available since 5 May 2021. The latest transaction was filed on 9 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Steven R. Loranger is a Director at Edwards Lifesciences Corp and Xylem Inc. In this role, he participates in the strategic direction of these companies and important decision-making. His expertise in the healthcare and water technology sectors is valuable to the board.